The session will include the presentation of the clinical data for NUZYRA. NUZYRA is a tetracycline-class antibacterial indicated for the treatment of adults with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Community-Acquired Bacterial Pneumonia (CABP) caused by susceptible microorganisms. This presentation will focus on ABSSSI.
This Satellite Symposium non-CME presentation is held in conjunction with the SAWC Fall 2023 Meeting. The opinions and recommendations expressed do not necessarily reflect the view of HMP Education or SAWC. This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE.